BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35031157)

  • 1. Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer.
    Fahy MR; Hayes C; Kelly ME; Winter DC
    Eur J Surg Oncol; 2022 Nov; 48(11):2284-2291. PubMed ID: 35031157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Difficulties and challenges of pelvic exenteration in locally advanced rectal cancer].
    Gu J; Gao QK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):215-221. PubMed ID: 36925120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic Pelvic Exenteration for Locally Advanced Rectal Cancer, Technique and Short-Term Outcomes.
    Pokharkar A; Kammar P; D'souza A; Bhamre R; Sugoor P; Saklani A
    J Laparoendosc Adv Surg Tech A; 2018 Dec; 28(12):1489-1494. PubMed ID: 29741977
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
    Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
    Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration for rectal cancer: a systematic review.
    Yang TX; Morris DL; Chua TC
    Dis Colon Rectum; 2013 Apr; 56(4):519-31. PubMed ID: 23478621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
    Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
    ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent involvement of anterior mesorectal fascia in carcinoma rectum - extended resection of rectum vs total pelvic exenteration: results from a single-centre retrospective study.
    Verma K; Engineer R; Ostwal V; Kumar S; Arya S; Desouza AL; Saklani AP
    Colorectal Dis; 2018 Dec; 20(12):1070-1077. PubMed ID: 29985547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
    Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
    Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.